Preferred
(EDT)

Immunotherapies for Hepatobiliary Cancers: Current Status and Future Perspectives

10:00 AM - 10:30 AM EDT
Wednesday, March 24, 2021Room: V300 Guy Coombes
Other
Advances in Molecular and Immune Targeting of Hepatobiliary Cancers

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.